drugset / Trial / NCT06739382
Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to determine the most effective empirical therapy of antibiotics for better ventilator-associated pneumonia control. The main question it aims to answer is: • Which is better for clinical response single or combination empiric antibiotic therapies ?
Timeline
- Start
- 2021-01-01
- Primary completion
- 2021-12-01
- Completion
- 2022-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amikacin | Small molecule | — | — |
| Subject | Ertapenem | Small molecule | — | — |
| Subject | Meropenem | Small molecule | — | — |
| Subject | Polymyxin | Unknown | — | — |
| Subject | Tigecycline | Small molecule | — | — |